About China Nepstar Chain Drugstore (NYSE:NPD)
China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, www.star365.com. It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases.
Industry, Sector and Symbol:
- Industry: Retail - Drugs without Grocery
- Sub-Industry: N/A
- Sector: Retail - Drugs without Grocery
- Symbol: NYSE:NPD
- CUSIP: N/A
- Web: N/A
- Trailing EPS: $0.08
- Net Margins: 0.90%
- Return on Equity: 3.44%
- Return on Assets: 1.84%
- Outstanding Shares: 98,720,000
Frequently Asked Questions for China Nepstar Chain Drugstore (NYSE:NPD)
What is China Nepstar Chain Drugstore's stock symbol?
China Nepstar Chain Drugstore trades on the New York Stock Exchange (NYSE) under the ticker symbol "NPD."
How were China Nepstar Chain Drugstore's earnings last quarter?
China Nepstar Chain Drugstore Ltd. (NYSE:NPD) issued its earnings results on Wednesday, November, 25th. The company reported $0.00 earnings per share (EPS) for the quarter. The company had revenue of $124.77 million for the quarter. China Nepstar Chain Drugstore had a net margin of 0.90% and a return on equity of 3.44%. View China Nepstar Chain Drugstore's Earnings History.
Who are some of China Nepstar Chain Drugstore's key competitors?
Some companies that are related to China Nepstar Chain Drugstore include Xactly Corp (XTLY), Bristow Group (BRS), Basic Energy Services (BAS), Oasis Midstream Partners LP (OMP), Community Healthcare Trust Incorporated (CHCT), Rally Software Development Corp (RALY), International Seaways (INSW), Ciner Resources LP (CINR), Sutherland Asset Management Corp. (SLD), Castlight Health, inc. (CSLT), One Liberty Properties (OLP), Imprivata (IMPR), Omega Protein Corporation (OME), XO Group (XOXO), Ellington Financial LLC (EFC), Community Health Systems (CYH), Blount International (BLT) and Capital Senior Living Corporation (CSU).
How do I buy China Nepstar Chain Drugstore stock?
Shares of China Nepstar Chain Drugstore can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Nepstar Chain Drugstore's stock price today?
One share of China Nepstar Chain Drugstore stock can currently be purchased for approximately $2.55.
How big of a company is China Nepstar Chain Drugstore?
China Nepstar Chain Drugstore has a market capitalization of $252.44 million.
How can I contact China Nepstar Chain Drugstore?
China Nepstar Chain Drugstore's mailing address is 6th Floor, Tower B, Xinnengyuan Building Nanhai Road Nanshan District, SHENZHEN, GNG 518057, China. The company can be reached via phone at +86-755-26435319.
MarketBeat Community Rating for China Nepstar Chain Drugstore (NYSE NPD)MarketBeat's community ratings are surveys of what our community members think about China Nepstar Chain Drugstore and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for China Nepstar Chain Drugstore (NYSE:NPD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for China Nepstar Chain Drugstore (NYSE:NPD)
Analysts' Ratings History for China Nepstar Chain Drugstore (NYSE:NPD)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for China Nepstar Chain Drugstore (NYSE:NPD)
Earnings History by Quarter for China Nepstar Chain Drugstore (NYSE NPD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|9/2/2015||Q215||$0.01||$686.55 million||$775.08 million||View||Listen|
Earnings Estimates for China Nepstar Chain Drugstore (NYSE:NPD)
No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for China Nepstar Chain Drugstore (NYSE:NPD)
|Most Recent Dividend:||1/24/2014|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Trailing 12 Months of Earnings) |
Dividend History by Quarter for China Nepstar Chain Drugstore (NYSE NPD)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for China Nepstar Chain Drugstore (NYSE NPD)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for China Nepstar Chain Drugstore (NYSE:NPD)
Latest Headlines for China Nepstar Chain Drugstore (NYSE NPD)
Financials are not available for this stock.
China Nepstar Chain Drugstore (NYSE NPD) Chart for Saturday, November, 18, 2017